The role of SOCS-3 in leptin signaling and leptin resistance

被引:494
作者
Bjorbæk, C
El-Haschimi, K
Frantz, JD
Flier, JS
机构
[1] Harvard Univ, Sch Med, Dept Med, Div Endocrinol,Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA
关键词
D O I
10.1074/jbc.274.42.30059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We earlier demonstrated that leptin induces expression of SOCS-3 mRNA in the hypothalamus. Furthermore, transfection data suggest that SOCS-3 is an inhibitor of leptin signaling. However, little is known about the regulation of SOCS-3 expression by leptin and the mechanism by which SOCS-3 inhibits leptin action. We here show that in CHO cells stably expressing the long form of the leptin receptor (CHO-OBRl), leptin induces transient expression of endogenous SOCS-3 mRNA but not of CIS, SOCS-1, or SOCS-2 mRNA. SOCS-3 protein levels were maximal after 2-3 h of leptin treatment and remained elevated at 20 h. Furthermore, in leptin-pretreated CHO-OBRl cells, proximal leptin signaling was blocked for more than 20 h after pretreatment, thus correlating with increased SOCS-3 expression. Leptin pretreatment did not affect cell surface expression of leptin receptors as measured by I-125-Peptin binding assays. In transfected COS cells, forced expression of SOCS-3 results in inhibition of leptin-induced tyrosine phosphorylation of JAK2. Finally, JAK2 co-immunoprecipitates with SOCS-3 in lysates from leptin-treated COS cells. These results suggest that SOCS-3 is a leptin-regulated inhibitor of proximal leptin signaling in vivo. Excessive SOCS-3 activity in leptin-responsive cells is therefore a potential mechanism for leptin resistance, a characteristic feature in human obesity.
引用
收藏
页码:30059 / 30065
页数:7
相关论文
共 44 条
[11]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[12]   Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor [J].
Dey, BR ;
Spence, SL ;
Nissley, P ;
Furlanetto, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :24095-24101
[13]  
Elmquist JK, 1998, J COMP NEUROL, V395, P535
[14]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[15]   The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line [J].
Ghilardi, N ;
Skoda, RC .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (04) :393-399
[16]   Defective STAT signaling by the leptin receptor in diabetic mice [J].
Ghilardi, N ;
Ziegler, S ;
Wiestner, A ;
Stoffel, R ;
Heim, MH ;
Skoda, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) :6231-6235
[17]   WEIGHT-REDUCING EFFECTS OF THE PLASMA-PROTEIN ENCODED BY THE OBESE GENE [J].
HALAAS, JL ;
GAJIWALA, KS ;
MAFFEI, M ;
COHEN, SL ;
CHAIT, BT ;
RABINOWITZ, D ;
LALLONE, RL ;
BURLEY, SK ;
FRIEDMAN, JM .
SCIENCE, 1995, 269 (5223) :543-546
[18]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314
[19]   Twenty proteins containing a C-terminal SOCS box form five structural classes [J].
Hilton, DJ ;
Richardson, RT ;
Alexander, WS ;
Viney, EM ;
Willson, TA ;
Sprigg, NS ;
Starr, R ;
Nicholson, SE ;
Metcalf, D ;
Nicola, NA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :114-119
[20]   CYTOKINE RECEPTOR SIGNALING [J].
IHLE, JN .
NATURE, 1995, 377 (6550) :591-594